Objective: Stigma is described as highly relevant to the treatment context for opioid use disorder (OUD) partly because it is known to influence providers’ treatment decisions and care provision. However, further study is needed to directly test the salience of stigmatizing views for healthcare decision-making among providers, and particularly those including medication for opioid use disorder (MOUD). This study assessed whether stigma toward illicit opioid use was associated with a willingness to provide or refer patients for MOUD treatment among a sample of healthcare providers. It also evaluated variation in stigmatizing views as a function of familiarity with OUD andMOUD and provider type. Method: Structural equation modeling was utilized to evaluate the antecedents and healthcare decision-making consequences associated with stigma based on survey data from a sample of 144 clinicians participating in a buprenorphine waiver training program (30% female). Results: Providers who have less familiarity with OUD and MOUD and those who are medical students or residents are significantly more likely to endorse stigmatizing views of illicit opioid use. In turn, greater stigma is significantly associated with a lesser willingness to provide treatment or refer patients to MOUD treatment.

Original languageEnglish
Pages (from-to)222-227
Number of pages6
JournalPsychology of Addictive Behaviors
Issue number2
StatePublished - Mar 28 2022

Bibliographical note

Funding Information:
This research is supported by a University of Kentucky Substance Use Priority Research Area grant awarded to the first author

Publisher Copyright:
© 2022 American Psychological Association


  • MOUD
  • healthcare providers
  • opioid use disorder
  • stigma

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology
  • Medicine (miscellaneous)


Dive into the research topics of 'Opioid Use-Related Stigma and Health Care Decision-Making'. Together they form a unique fingerprint.

Cite this